Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation (Q60455157)
Jump to navigation
Jump to search
scientific article published on 22 February 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation |
scientific article published on 22 February 2013 |
Statements
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation (English)
Leighton Clancy
Renee Simms
Chun K K Ma
Jane Burgess
Shivashni Deo
Karen Byth
Ming-Celine Dubosq
22 February 2013